Sandoz’s Choice: Extend the Statutory Stay and Adjourn Trial or Forego New Invalidity Defences06 Oct 2022Marcus KleeThe Federal Court granted Sandoz Canada Inc. leave to amend its Statement of Defence in an action under the Patented Medicines (Notice...Read More